SARS–CoV–2 ProtectAbility assay


In collaboration with the Institute of Organic Chemistry and Biochemistry and the Immunotech company, we have developed an ELISA assay for the quantitative analysis of anti-SARS-CoV-2 neutralizing antibodies in human samples. The assay has been successfully outlicenced to Beckman Coulter for the further manufacture and distribution! Thanks to all lab members who contributed to this excellent translational research!